Raycision deliver the most competitive solution through endless innovation.
Raycision’s journey of innovation began around 2013, when our founding team pioneered CT image-guided precision radiotherapy systems for advanced cancer research at a top global medical institute.
In 2015, we developed “3D optical & CT” multi-modality imaging systems for quantitative preclinical research. In 2017, we further upgraded our multi-modality molecular imaging technology into precision radiotherapy platforms. In 2021, Raycision was founded to translate our original innovations and serve global scientific community.
We have since rolled out a full product portfolio covering ultra-high-resolution x-ray CT, precision 3D molecular imaging and multi-modality radiotherapy systems. Now, Raycision empower global research communities with cutting-edge biomedical imaging and radiation solutions, and stand as a reliable partner in advancing scientific discovery and innovation.
CT Image-Guided Technology
3D Optical Imaging Technology
Multimodal Image-Guided Radiation Therapy
Raycision Founded
Product Launch
Global Strategy
Raycision deliver the most competitive solution through endless innovation.
Redefine 3D Precision Metrology
Learning, Innovation, Passion, Ownership
Raycision Empowers Research and Industry with Imaging and Radiation Solutions Tailored to Your Exact Needs.